Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Hisse Senetlerindeki Sıralama #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Hisse Fiyatı
$0.00185055
Piyasa Değeri
$48.29K
Değişim (1 gün)
-3.55%
Değişim (1 yıl)
30.31%
Ülke
GB
Ticaret Nuformix plc (NFX)

Kategori

Nuformix plc (NFX) için kazanç
Mar 2026 itibarıyla kazanç TTM: $-857.89K
Nuformix plc şirketinin en son finansal raporlarına göre, mevcut kazancı $-857.89K'dir. 2024 yılında şirket $-4.88M kazanç elde etti, bu 2023 yılındaki $-754.56K kazanca göre önceki yıla göre azalma. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Nuformix plc için kazanç geçmişi 2014 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $-857.89K -3.39%
2025 $-888.01K -81.80%
2024 $-4.88M 546.72%
2023 $-754.56K -54.82%
2022 $-1.67M -11.94%
2021 $-1.90M 64.37%
2020 $-1.15M -51.92%
2019 $-2.40M -12.87%
2018 $-2.75M 220.48%
2017 $-859.40K 70.68%
2016 $-503.51K -206.04%
2014 $474.83K 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$5.27B -614,967.33%
US
$-3.09B 359,735.34%
US
$-4.02B 468,046.88%
AU
$1.95B -227,477.01%
NL
- -
CH